Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 19;12(6):779-786.
doi: 10.5498/wjp.v12.i6.779.

Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective

Shu Wang  1 , Yu-Guang Guan  2 , Yan-Hua Zhu  3 , Min-Zhong Wang  4
Affiliations
Review

Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective

Shu Wang et al. World J Psychiatry. .

Abstract

As a common and serious psychiatric disorder, depression significantly affects psychosocial functioning and quality of life. However, the mechanism of depression is still enigmatic and perplexing, which limits its precise and effective therapeutic methods. Recent studies demonstrated that neuroinflammation activation plays an important role in the pathophysiology of depression. In this respect, high mobility group box 1 (HMGB1) may be a possible signaling inducer of neuroinflammation and can be a potential mechanistic and therapeutic target for depression. Herein, we review recent studies on the mechanistic and therapeutic targets of HMGB1 in depression and propose potential perspectives on this topic.

Keywords: Depression; High mobility group box 1; Mechanism; Neuroinflammation; Perspective; Review.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Illustration of mechanistic and therapeutic perspective of high mobility group box 1 in depression. HMGB1: High mobility group box 1; TLRs: Toll-like receptors; RAGE: Receptors for advanced glycation end products; CXCR4: C-X-C motif chemokine receptor 4.
See this image and copyright information in PMC

References

    1. Tran BX, Ha GH, Nguyen DN, Nguyen TP, Do HT, Latkin CA, Ho CSH, Ho RCM. Global mapping of interventions to improve quality of life of patients with depression during 1990-2018. Qual Life Res. 2020;29:2333–2343. - PubMed
    1. Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of Depression in the Community from 30 Countries between 1994 and 2014. Sci Rep. 2018;8:2861. - PMC - PubMed
    1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. - PMC - PubMed
    1. Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. J Psychiatr Res. 2020;126:134–140. - PubMed
    1. Wang S, Zhang Y, Ding W, Meng Y, Hu H, Liu Z, Zeng X, Wang M. Psychological distress and sleep problems when people are under interpersonal isolation during an epidemic: A nationwide multicenter cross-sectional study. Eur Psychiatry. 2020;63:e77. - PMC - PubMed